• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本人群中的红细胞膜疾病:临床、生化、电子显微镜及遗传学研究。

Red cell membrane disorders in the Japanese population: clinical, biochemical, electron microscopic, and genetic studies.

作者信息

Yawata Y, Kanzaki A, Inoue T, Ata K, Wada H, Okamoto N, Higo I, Yawata A, Sugihara T, Yamada O

机构信息

Department of Medicine, Kawasaki Medical School, Japan.

出版信息

Int J Hematol. 1994 Jul;60(1):23-38.

PMID:7919236
Abstract

Based on studies on 610 cases of hereditary red cell membrane disorders, the characteristic features of the incidence of these disorders in the Japanese population are described. These patients were screened by a protocol on red cell morphology (scanning electron microscopy), on red cell membrane proteins (sodium dodecylsulfate polyacrylamide gel electrophoresis, and kinetics of membrane proteins), biophysical studies (ektacytometry, mechanical stability and fluorescence recovery after the photobleaching method), membrane transport (sodium influx and efflux, and anion transport), gene analysis (spectrins, band 4.2 and band 3), surface markers (blood type antigens and sialic acid content), and development and expression of membrane proteins (using a two-phase liquid culture system). Among the molecular abnormalities detected, alpha-spectrin mutation appeared rare (only one family with spectrin alpha I/74), as opposed to two beta-spectrin mutations in Japan out of seven worldwide cases. Two unrelated kindreds with a chromosomal abnormality; that is, del (8) (p11.2-p21.1), were found that involved the possible contribution of ankyrin to the pathogenesis of hereditary spherocytosis. Anomalies of a transmembrane domain of band 3 were detected in two independent kindreds with impaired anion transport. Among 16 HE patients, 13 cases were partially band 4.1 deficient. Complete band 4.2 deficiency of the Nippon type (GCT-->ACT at codon 142 in band 4.2 gene) was observed in 17 cases of 13 unrelated kindreds. Other forms of band 4.2 deficiency without the mutation were also detected in three kindreds. Band 7 deficiency was found in seven cases with hereditary stomatocytosis independent of the presence or absence of cation transport abnormalities. A relatively high incidence of hereditary high red cell membrane phosphatidylcholine hemolytic anemia was disclosed by the analysis of red cell membrane lipids.

摘要

基于对610例遗传性红细胞膜疾病的研究,描述了这些疾病在日本人群中的发病特征。这些患者通过红细胞形态学(扫描电子显微镜)、红细胞膜蛋白(十二烷基硫酸钠聚丙烯酰胺凝胶电泳和膜蛋白动力学)、生物物理研究(激光衍射法、机械稳定性和光漂白后荧光恢复法)、膜转运(钠流入和流出以及阴离子转运)、基因分析(血影蛋白、4.2带和3带)、表面标志物(血型抗原和唾液酸含量)以及膜蛋白的发育和表达(使用两相液体培养系统)等方案进行筛查。在检测到的分子异常中,α-血影蛋白突变似乎很少见(只有一个家族有血影蛋白αI/74),而在全球7例病例中,日本有2例β-血影蛋白突变。发现两个无关的家族存在染色体异常,即del(8)(p11.2-p21.1),这可能与锚蛋白在遗传性球形红细胞增多症发病机制中的作用有关。在两个独立的阴离子转运受损家族中检测到3带跨膜结构域异常。在16例遗传性椭圆形红细胞增多症(HE)患者中,13例部分缺乏4.1带。在13个无关家族的17例患者中观察到日本型(4.2基因第142密码子处GCT→ACT)的4.2带完全缺乏。在三个家族中还检测到其他无突变的4.2带缺乏形式。在7例遗传性口形红细胞增多症患者中发现了7带缺乏,与阳离子转运异常的有无无关。通过对红细胞膜脂质的分析,发现遗传性高红细胞膜磷脂酰胆碱溶血性贫血发病率相对较高。

相似文献

1
Red cell membrane disorders in the Japanese population: clinical, biochemical, electron microscopic, and genetic studies.日本人群中的红细胞膜疾病:临床、生化、电子显微镜及遗传学研究。
Int J Hematol. 1994 Jul;60(1):23-38.
2
[Characteristics of red cell membrane disorders in the Japanese population].[日本人群红细胞膜疾病的特征]
Rinsho Byori. 1997 Apr;45(4):367-76.
3
Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.日本人群中遗传性球形红细胞增多症的基因型和表型特征。
Int J Hematol. 2000 Feb;71(2):118-35.
4
[Disorders of the membrane skeleton of erythrocytes in hereditary spherocytosis and elliptocytosis: significance of the molecular defect for pathogenesis and clinical severity].[遗传性球形红细胞增多症和椭圆形红细胞增多症中红细胞膜骨架的紊乱:分子缺陷对发病机制和临床严重程度的意义]
Klin Padiatr. 1991 Jul-Aug;203(4):284-95. doi: 10.1055/s-2007-1025443.
5
[Cytoskeleton anomalies in disorders of red cell membrane proteins].[红细胞膜蛋白疾病中的细胞骨架异常]
Rinsho Ketsueki. 1991 Jun;32(6):573-9.
6
[Molecular pathology of the erythrocyte membrane. Erythrocyte membrane defects as a cause of congenital hemolytic anemia].[红细胞膜的分子病理学。作为先天性溶血性贫血病因的红细胞膜缺陷]
Monatsschr Kinderheilkd. 1989 Jul;137(7):368-79.
7
Hereditary Red Cell Membrane Disorders in Japan: Their Genotypic and Phenotypic Features in 1014 Cases Studied.日本的遗传性红细胞膜疾病:1014例研究病例的基因型和表型特征
Hematology. 2001;6(6):399-422. doi: 10.1080/10245332.2001.11746596.
8
Electron microscopic and physicobiochemical studies on disorganization of the cytoskeletal network and integral protein (band 3) in red cells of band 4.2 deficiency with a mutation (codon 142: GCT-->ACT).对具有突变(密码子142:GCT→ACT)的4.2带缺乏症患者红细胞中细胞骨架网络和整合蛋白(带3)紊乱的电子显微镜及物理生化研究。
Int J Hematol. 1994 Apr;59(3):157-75.
9
Uniquely higher incidence of isolated or combined deficiency of band 3 and/or band 4.2 as the pathogenesis of autosomal dominantly inherited hereditary spherocytosis in the Japanese population.在日本人群中,作为常染色体显性遗传的遗传性球形红细胞增多症的发病机制,带3和/或带4.2单独或联合缺乏的发生率独特地更高。
Int J Hematol. 1994 Dec;60(4):227-38.
10
[Erythrocyte membrane protein abnormalities in hereditary hemolytic anemias].[遗传性溶血性贫血中的红细胞膜蛋白异常]
Nouv Rev Fr Hematol Blood Cells. 1977;18(1):95-116.

引用本文的文献

1
Enhanced phosphocholine metabolism is essential for terminal erythropoiesis.增强的磷酸胆碱代谢对于终末红细胞生成是必需的。
Blood. 2018 Jun 28;131(26):2955-2966. doi: 10.1182/blood-2018-03-838516. Epub 2018 Apr 30.
2
Associations of protein 4.2 with band 3 and ankyrin.蛋白质4.2与带3蛋白和锚蛋白的关联。
Mol Cell Biochem. 2006 Sep;289(1-2):159-66. doi: 10.1007/s11010-006-9159-x. Epub 2006 May 23.
3
Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2.人红细胞膜蛋白4.2的血影蛋白结合域定位
Biochem J. 2002 Jun 15;364(Pt 3):841-7. doi: 10.1042/BJ20020195.
4
Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2.人红细胞膜蛋白4.2的棕榈酰化可结合带3结构域的定位
Biochem J. 1999 Jun 1;340 ( Pt 2)(Pt 2):505-12.